Table 3.
Control | LIET | HIET | |||||
---|---|---|---|---|---|---|---|
Pretraining | Posttraining | Pretraining | Posttraining | Pretraining | Posttraining | ANCOVA, p-value (Treatment, Time, Interaction) |
|
VO2 Peak, ml·kg-1·min-1 | 21.6 ± 4.1 | 20.9 ± 2.8 | 21.0 ± 3.5 | 22.8 ± 2.6* | 21.7 ± 4.1 | 24.7 ± 4.6*,¥ | (0.025, 0.023, 0.049) |
VO2 LT ,ml·kg-1·min-1 | 13.0 ± 2.5 | 14.5 ± 1.9 | 13.0 ± 2.1 | 13.2 ± 1.8 | 13.8 ± 2.3 | 14.6 ± 2.4 | (0.469, 0.042, 0.704) |
Treadmill VelocityPeak, m·min-1 | 113 ± 10 | 116 ± 5 | 114 ± 13 | 124 ± 14* | 116 + 10 | 136 ± 24*,¥,Ψ | (0.022, <0.001, 0.017) |
Treadmill VelocityLT, m·min-1 | 81 ± 9 | 90 ± 10 | 84 ± 7 | 87 ± 5 | 84 ± 10 | 88 ± 8 | (0.503, 0.003, 0.582) |
MET-H.Week-1 | 118.7 ± 46.6 | 152.2 ± 23.2 | 127.7 ± 53.5 | 122 ± 45 | 123.9 ± 56.6 | 149 ± 27 | (0.157, 0.157, 0.374) |
Basal Metabolic Rate, Kcal·day-1 | 1578 ± 150 | 1522 ± 103 | 1688 ± 294 | 1622 ± 263 | 1671 ± 284 | 1688 ± 187 | (0.254, 0.574, 0.445) |
Two-way, mixed-effects analysis of variance of covariance with repeated measures (ANCOVA) was employed to examine mean differences in pre-to posttraining values, with the baseline values serving as the covariate (see methods for details). For all analyses, linear contrasts of the means were constructed to test our a priori hypotheses. Fisher’s Restricted Least Significant Differences criterion was utilized to maintain the a priori type I error rate of 0.05.
Significantly different from baseline (p <0.05)
Significant treatment effect (post — pre) compared with NOET (p <0.05)
Significant treatment effect (post — pre) compared with LIET (p <0.05)